I think Berger's "greediness" serves us well now (allows for the greater possibility of buyout, allows us to sell rights later at a much appreciated price etc) but will be to our detriment later (if he tries to go this alone and commercialize this drug or any others throughout the world on his own I think we are looking at some problems)